INOVAIT, the Canadian image-guided therapy (IGT) and artificial intelligence (AI) network, is opening a call for applications for its Pilot Fund. The INOVAIT Pilot Fund is a reimbursement-based funding program to support collaborative research and development (R&D) projects that apply AI, machine learning, or big data to IGT technologies.
AI Tech Insights: Faros AI and Globant Partner to Drive Efficient Agentic AI-Based Projects
The Pilot Fund aims to help initiate the most promising IGT-AI projects to help improve patient outcomes and fuel economic development in Canada. This funding supports short-term IGT-AI commercialization-oriented R&D projects. Applying organizations can request up to $150,000 of non-dilutive investment, with INOVAIT contributing up to one-third of eligible supported costs in reimbursement funding.
To date, the INOVAIT Pilot Fund has committed just under $8M to support 65 IGT-AI projects across the country. Pilot Fund projects are selected based on their ability to demonstrate exceptional scientific, clinical, and technical merit, and their potential for high commercialization and economic impact.
AI Tech Insights: Groundbreaking Study Reveals the Biggest Threat to AI Initiatives Is Dirty Data
“The INOVAIT Pilot Fund is a proven medtech advancement program that accelerates the commercialization of Canada’s most innovative and impactful medical technologies,” states Kullervo Hynynen, Co-Executive Director of INOVAIT. “With each new round of the Pilot Fund, our enthusiasm grows as we discover and support groundbreaking medical technologies emerging from Canada’s leading companies, hospitals and universities.”
Funding for INOVAIT is provided through the Government of Canada’s Strategic Innovation Fund.
AI Tech Insights: Secret Network Joins Forces with DAIS to Champion Privacy in Decentralized AI
Source – PR Newswire
To share your insights, please write to us at news@intentamplify.com